Table 3

- Univariate analysis of risk factors for carbapenemase-encoding Pseudonomas aeruginosa infections.

VariablesUnivariate analysis
MDR-PA/CS-PAP-valueCR-MDR/CS-PAP-valueMDR-PA/CR-MDR-PAP-value
Gender
Male0.6360.5150.3490.1330.5490.078
Female      
Underlying diseases
Pulmonary disease3.2610.3025.1740.1491.5870.499
Gastrointestinal disease4.0760.3064.8850.2491.1990.795
Infectious disease7.3750.1692.8390.4950.3850.247
Malignancy1.3040.8291.0880.9470.8340.813
Neurologic disease6.5830.1621.8650.660.2830.136
Genitourinary disease1.240.882.2970.5551.8530.43
Cardiovascular disease1.7920.6180.6480.7230.3620.23
Bone----0.8660.859
Hematoma----0.8670.87
Specimens
Sputum4.2010.3392.5160.5170.5990.661
Urine2.7480.5455.1930.2971.890.6
Secretions*----1.3840.794
Pus----0.620.714
Tissue----0.7130.792
Blood----0.4640.563
Catheter      
ICU0.6320.5910.6650.6361.0510.905
Non-ICU      
Hat Yai Hospital1.3350.81523.0230.00917.2470
Songklanagarind Hospital      
Age      
0-12 years1.7420.6080.4970.5190.2850.023
13-24 years----0.5440.44
25-64 years2.1720.2820.6710.5840.3090.002
≥65 years      

Values are presented as an odds ratio (OR). *Penrose drain, bronchial wash, percutaneous nephrostomy, corneal ulcer, bile, and pleural fluid. CS-PA: carbapenem-susceptible Pseudonomas aeruginosa, MDR-PA: multidrug-resistant Pseudonomas aeruginosa, CR-MDR-PA: carbapenem-resistant multidrug-resistant Pseudonomas aeruginosa, ICU: intensive care unit